Earning Preview: Coca-Cola Femsa SAB de CV this quarter’s revenue is expected to increase by 23.23%, and institutional views are broadly bullish

Title

Earning Preview: Coca-Cola Femsa SAB de CV this quarter’s revenue is expected to increase by 23.23%, and institutional views are broadly bullish

Abstract

Coca-Cola Femsa SAB de CV will report its quarterly results on February 24, 2026 Pre-Market; consensus points to strong top-line and earnings acceleration supported by price-mix and operating leverage, with investors watching margin progression and currency effects into the new year.

Market Forecast

For the upcoming quarter, the company’s internal projections point to revenue of $4.32 billion, implying 23.23% year-over-year growth, EBIT of $710.54 million, implying 38.01% year-over-year growth, and adjusted EPS of $1.86, implying 32.67% year-over-year growth. While formal guidance for gross profit margin and net profit margin is not provided in the current forecast, the acceleration in EBIT and EPS signals expectations for margin improvement versus last year, contingent on pricing durability and input-cost trends.

Main operations remain anchored in the Products business, which historically represents the near entirety of sales and is expected to carry the bulk of this quarter’s revenue and earnings progression through continued price-mix, disciplined promotions, and volume normalization across key geographies.

The most promising revenue engine this quarter is the Products segment itself, which—if the mix holds near recent levels—could contribute about $4.30 billion out of the $4.32 billion total and mirror the company-wide year-over-year trajectory of roughly 23.23%, driven by pricing carryover, selective pack/channel expansion, and improved in-market execution.

Last Quarter Review

In the prior quarter, Coca-Cola Femsa SAB de CV delivered revenue of $3.86 billion (up 5.04% year over year), a gross profit margin of 45.06%, GAAP net profit attributable to shareholders of approximately $316.62 million based on an 8.20% net profit margin, and adjusted EPS of $1.51 (up 2.79% year over year).

A key financial highlight was operating leverage: EBIT rose to $552.78 million, up 8.59% year over year, with sequential profitability also improving, setting a constructive baseline heading into the new reporting period.

On the business mix, the Products segment accounted for $3.85 billion (99.72% of total revenue), with its growth profile closely tracking the enterprise’s 5.04% year-over-year increase, underscoring the segment’s centrality to both revenue scale and earnings formation.

Current Quarter Outlook (with major analytical insights)

Products: Core Operations and Execution

Products underpin the company’s revenue scale and earnings power and remain the focal point for this quarter’s performance. The forecasted revenue lift to $4.32 billion reflects a combination of pricing carryover from 2025, improved pack/channel execution, and continued rationality in promotions that should preserve the price-mix achieved last year. Unit elasticity has been manageable in recent quarters, and the projected acceleration in EBIT and EPS signals that incremental margin should benefit from scale and overhead absorption, provided that volumes do not materially undershoot seasonal norms.

Input-cost dynamics are a pivotal swing factor. Resin, sweeteners, and aluminum costs moderated into late 2025, and contracts/hedges are expected to offer some protection against sudden spikes. If these input tailwinds persist, gross margin can hold the gains reported last quarter or expand modestly. However, management’s current-quarter forecast does not quantify margin; as such, investors will focus on the degree to which the anticipated EBIT growth of 38.01% year over year translates into operating margin gains in line with internal execution targets.

Foreign-exchange translation remains an ever-present variable for a multinational revenue base. Recent currency moves have been mixed across key markets, which could create noise in reported figures versus local-currency trends. The guidance-implied growth rates suggest that management anticipates sufficient price/mix and efficiency to offset translation headwinds in aggregate. Close attention will be paid to revenue per unit case and regional commentary in management’s release to gauge the durability of pricing without compromising volume recovery.

Most Promising Opportunity: Revenue Expansion Within Products

The company’s most compelling growth lever this quarter is the continued monetization of its Products portfolio via price/mix and channel strategy execution. Given that Products historically contribute virtually all of the company’s revenue, a stable mix would imply Products revenue near $4.30 billion this quarter, essentially mirroring the consolidated forecast. On a year-over-year basis, this suggests growth consistent with the company’s 23.23% top-line expectation, which, if achieved, would be a sharp step-up from the 5.04% year-over-year revenue growth reported in the previous quarter.

Within Products, premium packaging, evolving channel mix, and increased availability at the point of sale have been central to lifting revenue per case. The forecasted acceleration in EBIT and EPS relative to revenue also implies that incremental revenue may be converting at higher flow-through rates than in earlier periods, particularly if distribution efficiencies and scale benefits persist. For the upcoming print, investors will be looking for confirmation that higher-value single-serve and premium pack formats continue to outpace base volume, which would reinforce both the revenue and margin story embedded in management’s forecast.

An additional support to this narrative is the expected moderation in unit taxes and regulated cost components versus last year’s peaks in certain markets, which could further aid incremental profitability. Should these factors converge positively, the resulting operating leverage would validate the 38.01% year-over-year EBIT expansion implied by the forecast and position the business for a constructive 2026 earnings trajectory. Conversely, any indication that elasticities are building or that price/mix momentum is slowing would be the first place analysts would revisit top-line assumptions.

Key Stock Price Drivers This Quarter

Guidance quality and tone are likely to be the single biggest stock driver. The market will focus on whether management reiterates or upgrades qualitative commentary around price realization, the inflation outlook for key inputs, and the cadence of operating expenditure as volumes normalize. A reiteration of pricing durability alongside ongoing cost discipline would be consistent with the forecasted EPS jump to $1.86, which assumes robust drop-through from revenue to profit.

Currency is the next meaningful catalyst. The translation of local-currency results into U.S. dollar reporting can mask underlying momentum, so any disclosure that disaggregates mix and currency will be scrutinized. If foreign-exchange headwinds intensify, investors will assess whether stronger price/mix and cost control can preserve the projected 23.23% year-over-year revenue growth in reported terms. On the flip side, any favorable currency dynamics could amplify the earnings beat potential given the operating leverage apparent in the 38.01% year-over-year EBIT growth projection.

Cash discipline and capital allocation choices may also influence the near-term share reaction. With prior-quarter EBIT at $552.78 million and the current-quarter EBIT projected at $710.54 million, free cash flow conversion and working-capital trends will be watched for signals of how much of the earnings uplift translates into cash. Commentary on capex, route-to-market investments, and potential shareholder returns can add support to a beat-and-raise narrative. A balanced message—protecting growth investments while demonstrating cash-generation continuity—would likely reinforce the constructive analyst stance heading into the remainder of 2026.

Analyst Opinions

Across the most recent published views since January 1, 2026 and up to February 17, 2026, the ratio of bullish to bearish opinions stands at 3 to 2, with the majority side bullish. On the bullish side, several well-known institutions emphasize pricing resilience and improving margin prospects. A prominent global investment bank reaffirmed its Buy rating with a $111.00 price target, highlighting the company’s capacity to sustain favorable price-mix while maintaining disciplined cost structures. Another major house reiterated a Buy and lifted/affirmed its price target to $111.00, citing continued operating leverage and a clearer path to earnings growth in early 2026 as pricing initiatives annualize and input-cost pressures remain manageable. Additionally, a recent aggregation of analyst recommendations characterized the stock’s average stance as overweight, with a mean price target near $112.58, reinforcing the constructive skew of institutional views.

These bullish opinions coalesce around the view that the current-quarter forecast—revenue of $4.32 billion, EBIT of $710.54 million, and EPS of $1.86—sets a reasonable bar that can be achieved if execution on price-mix and cost control remains disciplined. The projected 23.23% year-over-year revenue growth aligns with an expected rebound in effective on-shelf availability and promotional rationality. Meanwhile, the implied 38.01% EBIT growth and 32.67% EPS growth suggest margin accretion that is credible given the prior-quarter baseline of a 45.06% gross margin and a continuous focus on procurement, logistics, and operating efficiency.

Bullish analysts also flag potential upside levers. If input-cost deflation is a touch better than embedded in current assumptions, or if foreign-exchange translation proves neutral to slightly favorable, the incremental margin on the anticipated revenue step-up could be higher than modeled. A clean beat on EBIT against the $710.54 million marker, paired with constructive commentary on cash conversion and near-term capital allocation, would likely strengthen confidence in a sustained 2026 earnings inflection. These views acknowledge that volumes must remain resilient to support the price-mix strategy, but they argue the company’s recent track record and forecast imply that such balance is achievable.

In sum, the majority view across institutions entering this report window is positive. The setup features credible top-line acceleration, a path to margin improvement, and the prospect of healthy free cash flow conversion if working-capital discipline holds. The concentration of business in Products simplifies the near-term thesis: execute on price-mix, manage costs and inputs, and neutralize currency as best as possible. If the company delivers close to its forecast on February 24, 2026 Pre-Market and pairs it with confident commentary for the next quarter, bullish analysts see room for estimate revisions that keep the stock’s constructive narrative intact through the early part of the year.